Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Policy Tracker

Full Bill Tracker

Every tracked proposal: pending, failed, superseded, stalled and enacted — across psychedelics, cannabis, kratom and 7-OH.

Paraguay

Bills tracked for this country and its states or regions.

1 of 1 tracked bills · newest recorded action first

  • Expediente D-2476902

    Bill regulating the cultivation, production, sale and medicinal and recreational use of cannabis and its derivatives (2024)

    1. IntroducedApr 12, 2024 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    No dated action recorded

    Listed as in process on the Congress file. This is a cannabis bill, not a psychedelics bill.

    Bill source (opens in a new tab)